The Global Chronic Disease Management Market was valued at USD 6.2 billion in 2024 and is estimated to grow at a CAGR of 11.7% to reach USD 18.8 billion by 2034, driven by the increasing prevalence of chronic conditions such as diabetes, cardiovascular diseases, and hypertension, which necessitate effective management strategies. Additionally, advancements in digital health technologies, including telehealth services, remote monitoring devices, and electronic health records, have transformed the landscape of chronic care. These technological advancements not only enhance care coordination and clinical decision-making but also support proactive interventions that prevent disease progression, minimize hospital readmissions, and increase treatment adherence, ultimately transforming chronic care delivery and boosting system-wide efficiency.
Additionally, they empower healthcare providers with real-time data insights, streamline communication between patients and care teams, and facilitate timely medication adjustments, all of which contribute to more responsive, patient-centered care and long-term health management. These tools also foster greater patient engagement by promoting self-monitoring, education, and accountability, which are essential for managing complex, long-duration conditions effectively.
The cardiovascular diseases segment was valued at USD 2.2 billion in 2024 and is anticipated to reach USD 6.3 billion by 2034. The rising incidence of conditions like coronary artery disease, heart failure, and hypertension has increased the demand for comprehensive management solutions. Telehealth platforms, wearable devices, and remote monitoring systems help in tracking vital signs such as blood pressure and heart rate, facilitating timely interventions, and enhancing patient compliance with treatment regimens.
In 2024, the providers segment dominated the market, accounting for 53.8% of the share, and is expected to grow at a CAGR of 11.5% from 2025 to 2034. Healthcare providers, including hospitals, clinics, and specialized care centers, are central to chronic disease management services. Integrating digital health technologies allows providers to offer continuous care, monitor patient progress, and adjust treatment plans as needed, leading to improved patient outcomes and satisfaction.
U.S. Chronic Disease Management Market accounted for USD 2.2 billion in 2024 and is projected to grow at a CAGR of 11.1% between 2025 and 2034. The country's advanced healthcare infrastructure, widespread adoption of digital health technologies, and supportive reimbursement policies contribute to this growth. The increasing prevalence of chronic conditions among the U.S. population further drives the demand for effective management solutions.
Key players in the Global Chronic Disease Management Market include ResMed, Veradigm, IBM Corporation, Amwell, Oracle Corporation, Teladoc Health, Cerner Corporation, HealthSnap, Medtronic, and Koninklijke Philips N.V. These companies are focusing on developing innovative solutions to enhance chronic disease management. Strategies such as expanding telehealth services, integrating artificial intelligence for predictive analytics, and forming partnerships with healthcare providers are being employed to strengthen their market presence. Additionally, investments in research and development aim to improve patient engagement and treatment outcomes, positioning these companies for sustained growth in the evolving healthcare landscape.
This product will be delivered within 2-4 business days.
Additionally, they empower healthcare providers with real-time data insights, streamline communication between patients and care teams, and facilitate timely medication adjustments, all of which contribute to more responsive, patient-centered care and long-term health management. These tools also foster greater patient engagement by promoting self-monitoring, education, and accountability, which are essential for managing complex, long-duration conditions effectively.
The cardiovascular diseases segment was valued at USD 2.2 billion in 2024 and is anticipated to reach USD 6.3 billion by 2034. The rising incidence of conditions like coronary artery disease, heart failure, and hypertension has increased the demand for comprehensive management solutions. Telehealth platforms, wearable devices, and remote monitoring systems help in tracking vital signs such as blood pressure and heart rate, facilitating timely interventions, and enhancing patient compliance with treatment regimens.
In 2024, the providers segment dominated the market, accounting for 53.8% of the share, and is expected to grow at a CAGR of 11.5% from 2025 to 2034. Healthcare providers, including hospitals, clinics, and specialized care centers, are central to chronic disease management services. Integrating digital health technologies allows providers to offer continuous care, monitor patient progress, and adjust treatment plans as needed, leading to improved patient outcomes and satisfaction.
U.S. Chronic Disease Management Market accounted for USD 2.2 billion in 2024 and is projected to grow at a CAGR of 11.1% between 2025 and 2034. The country's advanced healthcare infrastructure, widespread adoption of digital health technologies, and supportive reimbursement policies contribute to this growth. The increasing prevalence of chronic conditions among the U.S. population further drives the demand for effective management solutions.
Key players in the Global Chronic Disease Management Market include ResMed, Veradigm, IBM Corporation, Amwell, Oracle Corporation, Teladoc Health, Cerner Corporation, HealthSnap, Medtronic, and Koninklijke Philips N.V. These companies are focusing on developing innovative solutions to enhance chronic disease management. Strategies such as expanding telehealth services, integrating artificial intelligence for predictive analytics, and forming partnerships with healthcare providers are being employed to strengthen their market presence. Additionally, investments in research and development aim to improve patient engagement and treatment outcomes, positioning these companies for sustained growth in the evolving healthcare landscape.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2024
Chapter 5 Market Estimates and Forecast, by Disease Type, 2021-2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Type, 2021-2034 ($ Mn)
Chapter 7 Market Estimates and Forecast, by End Use, 2021-2034 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Region, 2021-2034 ($ Mn)
Chapter 9 Company Profiles
Companies Mentioned
The companies featured in this Chronic Disease Management market report include:- Active Health Technologies
- Amwell
- Apollo TeleHealth
- Epic Systems
- HealthSnap
- IBM
- Koninklijke Philips N.V.
- Medicross
- Medtronic
- Oracle
- ResMed
- ScienceSoft USA
- Teladoc
- TimeDoc Health
- Topcon Healthcare
- Veradigm
- ZEISS
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 170 |
| Published | May 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 6.2 Billion |
| Forecasted Market Value ( USD | $ 18.8 Billion |
| Compound Annual Growth Rate | 11.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 18 |
